Walgreens Boots Alliance Schedules Fiscal 2017 Second Quarter Earnings Announcement for 5 April 2017
DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal
2017 second quarter earnings results at 7 a.m. Eastern time Wednesday, 5
April 2017, followed by a one-hour conference call with Walgreens Boots
Alliance management beginning at 8:30 a.m. Eastern time.
The conference call will be simulcast through the Walgreens Boots
Alliance investor relations website at: http://investor.walgreensbootsalliance.com.
A replay of the conference call will be archived on the website for 12
months after the call.
The replay also will be available from 11:30 a.m. Eastern time, 5 April
2017 through 12 April 2017, by calling +1 855 859 2056 within the USA
and Canada, or +1 404 537 3406 internationally, using replay code
83158362.
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led,
health and wellbeing enterprise.
The company was created through the combination of Walgreens and
Alliance Boots in December 2014, bringing together two leading companies
with iconic brands, complementary geographic footprints, shared values
and a heritage of trusted health care services through pharmaceutical
wholesaling and community pharmacy care, dating back more than 100 years.
Walgreens Boots Alliance is the largest retail pharmacy, health and
daily living destination across the USA and Europe. Walgreens Boots
Alliance and the companies in which it has equity method investments
together have a presence in more than 25* countries and employ more than
400,000* people. The company is a global leader in pharmacy-led, health
and wellbeing retail and, together with the companies in which it has
equity method investments, has over 13,200* stores in 11* countries as
well as one of the largest global pharmaceutical wholesale and
distribution networks, with over 390* distribution centers delivering to
more than 230,000** pharmacies, doctors, health centers and hospitals
each year in more than 20* countries. In addition, Walgreens Boots
Alliance is one of the world’s largest purchasers of prescription drugs
and many other health and wellbeing products.
The company’s portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands such as No7,
Botanics, Liz Earle and Soap & Glory.
In October 2016 Walgreens Boots Alliance received the United Nations
Foundation Global Leadership Award for its commitment to the UN’s
Sustainable Development Goals. The company also ranks No. 1 in the Food
and Drug Stores industry of Fortune magazine’s 2017 list of the World’s
Most Admired Companies.
More company information is available at www.walgreensbootsalliance.com.
* As of 31 August 2016, using publicly available information for
AmerisourceBergen.
** For 12 months ending 31 August 2016, using publicly available
information for AmerisourceBergen.
(WBA-GEN)
Cautionary Note Regarding Forward-Looking Statements: All
statements in this release and related conference call and webcast that
are not historical are forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements are not guarantees of future
performance and involve risks, assumptions and uncertainties, including
those described in Item 1A (Risk Factors) of our Form 10-K for the
fiscal year ending 31 August 2016, which is incorporated herein by
reference, and in other documents that we file or furnish with the
Securities and Exchange Commission. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially. These forward-looking
statements speak only as of the date they are made. Except to the extent
required by law, we do not undertake, and expressly disclaim, any duty
or obligation to update publicly any forward-looking statement after the
date of this release, whether as a result of new information, future
events, changes in assumptions or otherwise.
Contacts
Media Relations
USA / Michael Polzin
+1 847 315 2935
or
International
/ Laura Vergani
+44 (0)207 980 8585
or
Investor
Relations
Gerald Gradwell and Ashish Kohli
+1 847 315 2922
